Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;147(4):883-893.
doi: 10.1378/chest.14-1677.

Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Gerard J Criner  1 , Jean Bourbeau  2 , Rebecca L Diekemper  3 , Daniel R Ouellette  4 , Donna Goodridge  5 , Paul Hernandez  6 , Kristen Curren  7 , Meyer S Balter  8 , Mohit Bhutani  9 , Pat G Camp  10 , Bartolome R Celli  11 , Gail Dechman  12 , Mark T Dransfield  13 , Stanley B Fiel  14 , Marilyn G Foreman  15 , Nicola A Hanania  16 , Belinda K Ireland  17 , Nathaniel Marchetti  18 , Darcy D Marciniuk  19 , Richard A Mularski  20 , Joseph Ornelas  3 , Jeremy D Road  21 , Michael K Stickland  22
Affiliations
Review

Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Gerard J Criner et al. Chest. 2015 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1 –
Figure 1 –
Decision tree for prevention of AECOPD according to three key clinical questions using the PICO format: nonpharmacologic therapies, inhaled therapies, and oral therapies. Note that the wording used is “recommended or not recommended” when the evidence was strong (level 1) or “suggested or not suggested” when the evidence was weak (level 2). ER = emergency room; ICS = inhaled corticosteroid; LABA = long-acting β2-agonist; LAMA = long-acting muscarinic antagonist; PDE4 = phosphodiesterase 4; PICO = population, intervention, comparator, outcome; SABA = short-acting β2-agonist; SAMA = short-acting muscarinic antagonist.
See this image and copyright information in PMC

References

    1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2013. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf. Accessed May 15, 2014. - PubMed
    1. Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD. Eur Respir Rev. 2006;15(99):32-36.
    1. Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103(3):325-334. - PubMed
    1. Public Health Agency of Canada. Chronic pulmonary obstructive disease (COPD). Public Health Agency of Canada website. http://www.phac-aspc.gc.ca/cd-mc/crd-mrc/copd-mpoc-eng.php. Accessed June 28, 2012
    1. Centers for Disease Control and Prevention; National Center for Health Statistics. Deaths: final data for 2009. Natl Vital Stat Rep. 2012;60(3):1-117. - PubMed

Publication types